ABI-1179
Recurrent Genital Herpes (HSV-2)
Phase 1bActive (Licensed to Gilead)
Key Facts
Indication
Recurrent Genital Herpes (HSV-2)
Phase
Phase 1b
Status
Active (Licensed to Gilead)
Company
About Assembly Biosciences
Assembly Biosciences is a focused antiviral specialist with a mission to develop innovative therapeutics for serious viral diseases. Its strategy is validated by a major partnership with Gilead Sciences, which licensed its lead herpesvirus programs, and a clinical pipeline featuring promising candidates for HSV-2, HDV, and HBV. The company applies a targeted platform approach to discover small molecules with novel mechanisms of action, aiming to address the limitations of current standards of care.
View full company profileTherapeutic Areas
Other Recurrent Genital Herpes (HSV-2) Drugs
| Drug | Company | Phase |
|---|---|---|
| ABI-5366 | Assembly Biosciences | Phase 1b |